logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Offsprings
Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Mr Nicholas Stephen Pass

    Related profiles found in government register
  • Mr Nicholas Stephen Pass
    British born in May 1959

    Resident in England

    Registered addresses and corresponding companies
  • Pass, Nicholas Stephen
    British born in May 1959

    Resident in England

    Registered addresses and corresponding companies
  • Pass, Nicholas Stephen
    born in May 1959

    Resident in England

    Registered addresses and corresponding companies
  • Pass, Nicholas Stephen
    British

    Registered addresses and corresponding companies
  • Pass, Nicholas Stephen

    Registered addresses and corresponding companies
  • Pass, Nicholas

    Registered addresses and corresponding companies
child relation
Offspring entities and appointments 13
  • 1
    CENTRAPHARM LIMITED
    - now 05184944 03235514... (more)
    DERMA UK LIMITED
    - 2005-10-11 05184944 03235514... (more)
    CENTRAPHARM LIMITED
    - 2005-08-30 05184944 03235514... (more)
    DERMA UK LIMITED
    - 2005-07-22 05184944 03235514... (more)
    Dissolved Corporate (5 parents)
    Officer
    2004-07-20 ~ dissolved
    IIF 8 - Director → ME
    2004-07-20 ~ dissolved
    IIF 21 - Secretary → ME
    Person with significant control
    2016-06-20 ~ dissolved
    IIF 3 - Has significant influence or control → OE
  • 2
    CRYSTACIDE PHARMA LIMITED
    04846699
    Dissolved Corporate (4 parents)
    Officer
    2003-07-28 ~ dissolved
    IIF 11 - Director → ME
  • 3
    DERMA EUROPE LIMITED
    05589356
    Dissolved Corporate (4 parents)
    Officer
    2005-10-11 ~ dissolved
    IIF 9 - Director → ME
  • 4
    DERMA UK HOLDINGS LIMITED
    09064486
    Active Corporate (3 parents, 1 offspring)
    Officer
    2014-05-30 ~ now
    IIF 12 - Director → ME
    2014-05-30 ~ now
    IIF 23 - Secretary → ME
    Person with significant control
    2016-06-20 ~ now
    IIF 5 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 5 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 5
    DERMA UK LIMITED
    - now 03235514 05184944... (more)
    CENTRAPHARM LIMITED
    - 2005-10-11 03235514 05184944... (more)
    DERMA UK LIMITED
    - 2005-08-30 03235514 05184944... (more)
    CENTRAPHARM LIMITED
    - 2005-07-22 03235514 05184944... (more)
    HIGHWOOD DESIGN AND TECHNOLOGY LIMITED - 2001-04-05
    INSIGHT DESIGN AND TECHNOLOGY LIMITED - 1998-01-12
    Active Corporate (9 parents, 4 offsprings)
    Officer
    2002-07-18 ~ now
    IIF 14 - Director → ME
    Person with significant control
    2016-06-20 ~ now
    IIF 4 - Has significant influence or control → OE
  • 6
    GP PHARMA HOLDINGS LIMITED
    09069049
    Dissolved Corporate (3 parents)
    Officer
    2014-06-03 ~ dissolved
    IIF 15 - Director → ME
    2014-06-03 ~ dissolved
    IIF 24 - Secretary → ME
  • 7
    GP PHARMA LIMITED
    04453696
    Dissolved Corporate (5 parents)
    Officer
    2002-06-02 ~ dissolved
    IIF 16 - Director → ME
    2003-03-28 ~ dissolved
    IIF 22 - Secretary → ME
  • 8
    LOGIC PHARMA LLP
    OC377638 07033225
    Dissolved Corporate (3 parents)
    Officer
    2012-08-14 ~ dissolved
    IIF 19 - LLP Designated Member → ME
    Person with significant control
    2016-06-20 ~ dissolved
    IIF 1 - Right to surplus assets - More than 25% but not more than 50% → OE
    IIF 1 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 1 - Has significant influence or control → OE
  • 9
    NPCG LIMITED
    - now 07033225
    LOGIC PHARMA LIMITED
    - 2012-08-08 07033225 OC377638
    Dissolved Corporate (2 parents)
    Officer
    2009-09-29 ~ dissolved
    IIF 7 - Director → ME
  • 10
    SEBCO PHARMA HOLDINGS LIMITED
    09069071
    Dissolved Corporate (3 parents)
    Officer
    2014-06-03 ~ dissolved
    IIF 17 - Director → ME
    2014-06-03 ~ dissolved
    IIF 25 - Secretary → ME
  • 11
    SEBCO PHARMA LIMITED
    - now 04163166
    HIGHWOOD DESIGN AND TECHNOLOGY LIMITED
    - 2003-04-15 04163166 03235514
    CENTRAPHARM LIMITED - 2001-04-05
    CASTLEWEST HEALTHCARE LIMITED - 2001-02-28
    Dissolved Corporate (6 parents)
    Officer
    2003-03-28 ~ dissolved
    IIF 13 - Director → ME
    Person with significant control
    2016-06-20 ~ dissolved
    IIF 6 - Has significant influence or control → OE
  • 12
    THE EMOLLIENT COMPANY LIMITED
    04753316
    Dissolved Corporate (4 parents)
    Officer
    2003-05-06 ~ dissolved
    IIF 10 - Director → ME
    2003-05-06 ~ dissolved
    IIF 20 - Secretary → ME
  • 13
    ULTRABASE PHARMA LLP
    OC377637
    Dissolved Corporate (3 parents)
    Officer
    2012-08-14 ~ dissolved
    IIF 18 - LLP Designated Member → ME
    Person with significant control
    2016-06-20 ~ dissolved
    IIF 2 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 2 - Right to surplus assets - More than 25% but not more than 50% → OE
    IIF 2 - Has significant influence or control → OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.